• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

diabetes dbm's


<











the diabetes dbm's are miserable. they have to overlap with 3 other managers. DS1, DS2, DS3, DS4. they are in the same crowded boat as the rbd's. too much duplication of effort.